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Objective: This study used a large national administrative in-hospital database to compare utilization and age-specific
outcomes between open repair (OAR) and endovascular (EVAR) repair for the treatment of abdominal aortic aneurysm
(AAA).
Methods: Discharges with the principal International Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) procedure codes for EVAR and OAR and principal diagnosis code of intact AAAs were selected from the
2001 to 2006 Nationwide Inpatient Sample (NIS). Weighted least-square regression was used to test the trend of
utilization by age. Multiple linear and logistic regression analyses were used to assess the risk-adjusted outcomes.
Results:Nationally, the estimated number of elective AAAs treated with EVAR increased from 11,171 in 2001 to 21,725
in 2006 (P  .003). The number of elective AAAs treated with OAR declined from 17,784 to 8451 during the same
period (P < .001). By 2006, EVAR was more frequently used than OAR for patients of all ages. Compared with the
younger age groups, patients aged>85 years had a significant increase in the total number of asymptomatic AAA repairs,
driven almost entirely by an increase in the use of EVAR. Compared with open patients, EVAR patients had a significantly
shorter length of hospitalization (adjusted mean, 2.99 days [95% confidence interval (CI), 2.97-3.01] vs 8.78 days [95%
CI, 8.53-8.57]), less in-hospital mortality (odds ratio [OR], 0.23; 95% CI, 0.19-0.28), fewer in-hospital complications
(OR, 0.27; 95% CI, 0.25-0.28), and a higher likelihood of being discharged to home (OR, 3.95; 95% CI, 3.62-4.31). The
reduction of complications from the use of EVAR versus OAR was most dramatic for the oldest patients.
Conclusions: As short-term surgical outcomes are consistently improving for patients undergoing AAA repair, elective
EVAR has replaced OAR as the more commonmethod of repair in the United States. The introduction of this technology
has been rapidly adopted, particularly for the oldest-old surgical patients, aged >85 years, who previously may not have
been offered surgical intervention for asymptomatic AAA. Further investigation is necessary to examine whether this
trend improves the long-term survival and quality of life for this elderly population. (J Vasc Surg 2009;50:722-9.)The goal of abdominal aortic aneurysm (AAA) repair is
to prevent aneurysm rupture, which has a mortality rate as
high as 80% and is responsible for 9000 deaths each year in
the United States.1,2 To this end, patients with asymptom-
atic AAAs are now typically offered two surgical options:
open aneurysm repair (OAR) or endovascular repair
(EVAR). For more than 50 years, OAR has been the
standard of care. However, since its introduction in the
early 1990s, EVAR has rapidly gained popularity.
Although long-term trials of EVAR versus OAR have
yet to show a difference in long-term survival between the
two procedures, short-term data clearly show an advantage
with endovascular stent grafting.3,4 Adoption of this new
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722technology has been rapid due to the significantly lower risk
profile. It is unknown whether diffusion of this technologic
advance has gone beyond the previous clinical boundaries
for OAR. In the past, these boundaries were commonly
restricted by the patient’s ability to withstand the physical
demands of an open procedure as opposed to the presence
of aneurysmal disease.
Historically, advances in technology are first applied to
the most robust patients who are most likely to tolerate
them.5 New technology, however, is subject to therapeutic
expansion, whereby application of innovative therapy is
extended beyond traditional boundaries to additional pa-
tients who may not have benefited from standard therapy
given the associated risk/benefit ratio.6 One example of
this phenomenon is the adoption of laparoscopic cholecys-
tectomy.7 Initially, a substantial savings in medical costs
due to a decrease in postoperative hospital and recovery
expenditures was predicted. In reality, the introduction of
laparoscopic cholecystectomy increased the overall costs of
cholelithiasis by driving an expansion of the indications for
the treatment of biliary disease to a previously untreated
group of patients.
The decision to repair an asymptomatic AAA is not
necessarily straightforward or solely based on aneurysm
size. Patient age appears to be an important factor in the
clinical decision-making process8,9; however, data about
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sparse.10-12 Furthermore, age-related data may be influ-
enced by the recent rapid diffusion of the use of EVAR. To
examine this issue in detail, we used a large administrative
database, the National Inpatient Sample (NIS), to quantify,
compare, and characterize the national utilization and op-
erative outcomes by age for OAR vs EVAR.
MATERIALS AND METHODS
Data source. TheNationwide Inpatient Sample (NIS)
is an annual database of hospital inpatient admissions that is
commonly used to identify national trends in health care
utilization and outcomes. It is a component of the Health-
care Cost and Utilization Project (HCUP) of the Agency
for Healthcare Research and Quality.13 NIS, a stratified
yearly sample of approximately 5 to 8 million hospital stays
from nearly 1000 hospitals, is the largest publicly available
all-payer inpatient care database in the United States, rep-
resenting approximately 20% of hospitals, including spe-
cialty, community and public hospitals, and academic med-
ical centers.12
Data records are patient-level clinical information in-
cluded in a typical hospital discharge abstract such as de-
mographics, diagnosis (principal and multiple secondary),
procedures (principal and multiple secondary), charges,
length of stay, and outcomes at discharge. The database
also contains hospital data from the American Hospital
Association Annual Survey of Hospitals, which includes
characteristics such as hospital location (rural vs urban),
geographic region, number of beds (small, medium, large),
and teaching status.
The NIS is distinct from the CMS Medicare claims
database in its ability to capture additional patients, includ-
ing those aged 64 years. Inpatient care for all-payment
sources, including the uninsured and Medicare patients
enrolled in HMOs, are also included in the NIS.
We include NIS data from 2001 to 2006 because the
International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) codes specific to en-
dovascular aortic repair were not available until October
2000. Data from 2006 were the most recent available
from the NIS. United States population data, obtained
through the Census Bureau’s Web site (www.census.
gov), were used to adjust for the population change
during the study period.
Data classification. We include all discharges with an
ICD-9-CM principal diagnosis code for intact AAA
(441.4) and primary procedure codes (39.71); endovascu-
lar repair of AAA with graft and resection of abdominal
aorta with replacement (38.44).14 For the purpose of ho-
mogeneity, we excluded from the analysis patients aged50
years and those with secondary diagnostic codes for ruptured
AAA (441.3, 441.5), aortic dissection (441.0), thoracic or
thoracoabdominal aortic aneurysm (441.1, 441.2, 441.6,
441.7), coarctation of the aorta (747.1), Marfan syndrome
and other congenital anomalies (759.8), gonadal dysgenesis-
Turner syndrome (758.6), and polyarteritis nodosa(446.0).15 Only patients with elective admissions were
included in the analysis.
Covariates. We used results of a literature review of
ICD-9-CM codes for complications16-18 to compile a list
of codes specifically designed for surgical complications
(starting with 996-999) and codes indicating acute condi-
tions complicating surgical operations such as acute myo-
cardial infarction (Appendix I, online only). Codes were
grouped as cardiovascular, pulmonary, peripheral vascular,
acute renal failure, infection, postoperative shock, bleed-
ing, and wound complications. We also used secondary
diagnoses9,19 to assess the comorbidities of coronary artery
diseases, cerebral vascular disease, peripheral vascular dis-
ease, chronic obstructive pulmonary disease (COPD), dia-
betes, and chronic renal insufficiency (Appendix II, online
only).
To control for the influence of hospital characteristics
on short-term surgical outcomes in our multivariate regres-
sion models, we used the NIS variables of hospital location
(rural vs urban), teaching status, and number of beds
(small, medium, or large). We calculated the total volume
of AAA repair procedures at each hospital. We derived
hospital volume of OAR or EVAR by counting the total
number of discharges with primary or secondary procedure
codes of 38.44 (OAR) or 39.71 (EVAR) for each hospital
in each given year. Because the measure of hospital volume
was positively skewed, a logarithmic transformation was
used when the variable of hospital surgical volume was used
in regression models.
Statistical analysis. We estimated utilization rates of
OAR and EVAR. Given that NIS is a stratified random
sample, these estimates were calculated using the sampling
strata and weights provided by the HCUP. Weighted least-
squares regressions were used to assess population trends
from 2001 through 2006.20
Early postoperative outcomes include length of hos-
pital stay, in-hospital mortality rate, the proportion of
discharges to home versus total discharges, and in-hospital
complications. Mortality and complication rates were
computed as the estimated number of each event divided
by the estimated number of procedures performed during
the study period. Multivariate linear regression was used to
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Fig 1. Annual estimates of number of discharges for endovascular
and open repairs from 2001 to 2006.examine the risk-adjusted association between the type of
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effect of the procedure performed (EVAR vs OAR) on
in-hospital mortality, rate of discharge to home, and the
occurrence of complications, we used multivariate logistic
regression analyses. All models were adjusted for patient
comorbidities, gender, ZIP-code of residence as a proxy for
income, and hospital characteristics (location, number of
beds, teaching status, and the logarithmic transformation
of hospital surgical volume), and the year the operative
procedure was performed. Statistical significance for pre-
dictor coefficients was defined as P  .05. Statistical analy-
ses were performed using SAS 9.1.3 software (SAS Institute
Table I. Utilization trend of endovascular and open repai
Type of repair 2001 2002 2003
Endovascular
Age group
All ages
Discharges, No. 11171 11579 14068
Per capitaa 14 14 17
1 comorbidity, % 72.0 73.1 72
50-64 y
Discharges, No. 1562 1482 1908
Per capitaa 4 3 4
1 comorbidity, % 70.9 69.7 74
65-74 y
Discharges, No. 4467 4490 5333
Per capitaa 24 25 29
1 comorbidity, % 74.5 75.7 74
75-84 y
Discharges, No. 4452 4765 5755
Per capitaa 35 37 45
1 comorbidity, % 72.3 72.6 72
85 y
Discharges, No. 691 841 1072
Per capitaa 16 18 23
1 comorbidity, % 55.4 67.6 69
Open
Age group
All ages
Discharges, No. 17784 15323 12921
Per capitaa 23 19 16
1 comorbidity, % 72.8 71.5 73
50-64 y
Discharges, No. 3103 2579 2354
Per capitaa 7 6 5
1 comorbidity, % 67.6 68.9 70
65-74 y
Discharges, No. 8062 6572 5550
Per capitaa 44 36 30
1 comorbidity, % 75.4 73.7 75
75-84 y
Discharges, No. 6082 5664 4595
Per capitaa 48 44 36
1 comorbidity, % 73.0 71.0 72
85 y
Discharges, No. 536 508 422
Per capitaa 12 11 9
1 comorbidity, % 61.8 62.6 64
aDischarges per 100,000.Inc, Cary, NC).RESULTS
Utilization analysis. The trend for elective AAA re-
pairs in the United States between 2001 and 2006 is shown
in Fig 1. In 2001 the estimated number of procedures
was 17,784 for OAR and 11,171 for EVAR that met our
study criteria for elective operation performed on pa-
tients aged 50 years for AAA (Table I). In 2006 the
estimated number of OAR for intact AAAs decreased to
8451 and the estimated number of EVARs increased to
21,725 (Table I). After adjusting for national population
changes during the same period, these operations reflect
m 2001 to 2006
r
Change % P2004 2005 2006
15857 16525 21725 94 .003
19 19 24 71 .004
74.2 75.7 76.8 .001
2057 2411 3363 115 .009
4 5 6 50 .009
71.1 74.0 74.7 .071
5908 5980 7851 76 .008
32 32 42 75 .008
76.6 77.8 77.9 .022
6623 6755 8703 95 .002
51 52 67 91 .002
74.3 75.4 77.6 .007
1270 1378 1808 162 .001
26 27 34 113 .001
67.3 70.7 72.4 .050
11359 9384 8451 –52 .001
13 11 9 –61 .001
74.8 73.9 79.1 .038
2257 1988 1786 –42 .001
5 4 3 –57 .001
73.8 70.6 75.0 .016
4695 3743 3537 –56 .001
25 20 19 –57 .001
76.2 77.4 81.5 .038
4055 3385 2867 –53 .001
31 26 22 –54 .001
74.7 73.5 80.1 .001
353 268 261 –51 .001
7 5 5 –58 .001
63.5 55.7 63.0 0.710rs fro
Yea
.9
.0
.1
.0
.3
.4
.8
.9
.7
.0a per capita decrease of 61% (P  .001) for OAR and a
rs; an
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the 6 years studied.
Fig 2 shows the estimated number of AAA procedures
performed, stratified by age group. For each age group,
there is a reduction in the number of OARs performed
associated with an increase in the number of EVARs per-
formed from 2001 to 2006; however, the shift to EVAR is
less pronounced for younger patients aged 50 to 64 years.
Strikingly, the number of EVARs for patients aged 85
years increased 162% in this 6-year period (Table I). This
translates to an increase in the total number of AAA repairs
for this oldest group of patients by 69%.
Short-term operative outcomes. From 2001 to
2006, the mean length of stay was 2.67 to 3.30 days for
EVAR and 8.33 to 9.01 days for OAR (Table II). In-
hospital mortality was 0.64% to 1.23% for EVAR and 3.19%
to 4.24% for OAR. Among patients who were discharged
alive, 94.4% to 95.0% were discharged to home after un-
dergoing elective EVAR and 82.8% to 86.7% were dis-
charged to home after undergoing elective OAR. During
hospitalization, at least one of the complications we exam-
ined occurred in 10.95% to 14.6% of patients undergoing
EVAR and in 32.0% to 40.0% of patients undergoing OAR
(Table II).
Data from all 5 years were pooled to determine the
age-specific short-term operative outcomes (Table III).
Compared with the elderly, younger patients had a shorter
length of hospital stay, a higher proportion of routine
discharge to home, and fewer rates of in-hospital death and
complications. The in-hospital mortality rate was 0.3%,
0.8%, 1.0%, and 1.5% for patients aged 50 to 64, 65 to 74,
75 to 84, and85 years who had elective EVAR compared
with 1.2%, 2.5%, 5.6%, and 9.5% for patients who had
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Fig 2. Annual estimates of number of discharges of end
(A) 50 to 64 years, (B) 65 to 74 years, (C) 75 to 84 yeaelective OAR. Among patients who were discharged alive,85% were discharged to home in each age group after
elective EVAR. Although the rate of routine discharge after
OAR was comparable with EVAR in patients aged 50 to 64
and 65 to 74 years, the rate of routine discharge for older
patients was much lower, at 71.5% for patients aged 75 to
84 years and 40.2% for patients aged 85 years.
Similarly, fewer complications occurred in patients dur-
ing hospitalization for elective EVAR than in those hospi-
talized for elective OAR, and this was most pronounced in
the elderly. Notably, patients aged 75 to 84 and patients
aged 85 years undergoing OAR had a 10% risk of
cardiovascular complications, pulmonary complications,
and acute renal failure, compared with a 5% risk of
complications in patients of similar age undergoing EVAR.
After adjusting for patient-specific covariates, including
gender, income level, insurance status, comorbidities, and
hospital-specific covariates including location, size, teach-
ing status, and surgical volume, we found that patients who
had elective EVAR had significantly better early outcomes
than patients who had elective OAR overall and for each
age group (Table IV). For example, adjusted mean length
of stay was 2.5, 2.84, 3.19, and 3.54 days for patients
undergoing elective EVAR in our defined age groups of 50
to 64, 65 to 74, 75 to 84, and 85 years, respectively,
compared with 7.3, 8.2, 9.52, and 9.91 days for patients
undergoing elective OAR. The magnitude of the benefit
offered by EVAR appears to increase with advancing age.
For example, the adjusted odds ratio (OR) of EVAR versus
OAR for routine discharge was 5.17 in patients aged 85
years compared with 3.95 in those aged 50 to 64 years.
Similarly, patients in the older age groups had greater
benefit from EVAR in terms of in-hospital death, cardio-
vascular complications, pulmonary complications, and
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ovascacute renal failure than the younger cohort. EVAR had an
urysm
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not more pronounced for those of advanced age; OR of
EVAR versus OAR were 0.47, 0.40, 0.59, and 0.61 for
patients aged 50 to 64, 65 to 74, 75 to 84, and85 years,
respectively.
DISCUSSION
The outcomes of endovascular techniques for repair of
AAAs have been a focus of intense research since the
introduction of this new technology. Initially, device-
specific clinical trials comparing EVAR and OAR reported
Table II. Outcomes of endovascular repair and open repa
Type of repair 2001 2002
Endovascular
Hospital LOS, mean d 3.30 3.30
In-hospital mortality, % 1.02 0.92
Discharge to home, % 94.79 94.77
Complications, % 14.33 14.44
Cardiovascular 3.51 3.13
Pulmonary 3.58 3.80
Acute renal failure 2.59 2.05
Infection 0.71 0.71
Postoperative shock 0.13 0.04
Bleeding 7.35 7.40
Wound 0.23 0.08
Open
Hospital LOS, mean, d 8.33 8.55
In-hospital mortality, % 3.19 3.49
Discharge to home, % 86.72 85.44
Complications, % 32.02 33.74
Cardiovascular 8.85 8.80
Pulmonary 15.21 16.45
Acute renal failure 5.74 7.41
Infection 2.34 3.14
Postoperative shock 0.49 0.38
Bleeding 11.04 12.24
Wound 0.95 1.09
LOS, Length of stay.
Table III. Age-specific outcomes of endovascular and ope
Outcomes
50-64 y
EVAR OAR EVAR
Hospital LOS, mean, d 2.5 7.3 2.9
In-hospital mortality, % 0.3 1.2 0.8
Discharge to home, % 98.1 94.9 96.1
1 complications, % 8.8 27.3 11.0
Complication
Cardiovascular 1.9 6.3 2.7
Pulmonary 2.3 12.8 3.3
Acute renal failure 1.3 4.8 1.8
Infection 0.5 2.7 0.6
Postoperative shock 0.0 0.4 0.1
Bleeding 4.3 9.2 5.0
Wound 0.2 0.9 0.2
EVAR, Endovascular aneurysm repair; LOS, length of stay; OAR, open anecomparable mortality rates between these two proce-dures.21-24 Concurrently, retrospective reviews demon-
strated a short-term operative mortality advantage of
EVAR.7,9,11,25 For example, 2003 data from the New York
State discharge database demonstrated an operative mor-
tality for elective AAA of 0.8% for EVAR and 4.2% for
OAR.26 Our study, using the most recent years of the NIS,
confirms these short-term advantages offered by EVAR.
Given its observational nature, our study may reflect
bias in that only anatomically suitable infrarenal AAAs were
approached with EVAR, leaving the more anatomically
challenging aneurysms for OAR.However, our findings are
all ages
Year
2003 2004 2005 2006
3.07 2.88 3.06 2.67
0.77 0.72 1.23 0.64
95.03 94.72 94.40 94.80
14.60 13.06 13.25 10.95
3.75 2.97 3.33 2.41
3.14 2.99 3.85 2.48
2.02 2.15 2.74 2.40
0.81 0.61 1.00 0.48
0.10 0.03 0.09 0.24
7.97 7.31 6.04 5.45
0.20 0.12 0.12 0.08
8.46 8.46 9.01 8.78
3.74 3.41 4.24 3.59
85.41 83.21 82.84 82.67
37.03 36.78 39.64 39.57
9.68 7.57 8.54 8.91
17.81 17.50 20.84 19.81
7.98 9.11 9.61 11.08
2.60 3.64 3.82 4.54
0.67 0.54 1.35 1.23
13.86 13.70 13.57 13.70
1.42 0.98 1.28 0.94
pairs
y 75-84 y 85 y
OAR EVAR OAR EVAR OAR
8.2 3.2 9.5 3.5 9.9
2.5 1.0 5.6 1.5 9.5
88.0 92.3 71.5 85.6 50.2
34.1 15.7 41.0 17.9 48.9
7.6 3.7 10.9 4.2 13.9
16.5 3.5 20.4 3.1 25.3
7.3 3.0 10.4 3.0 11.7
2.6 0.9 3.9 0.6 5.5
0.6 0.1 0.9 0.2 1.3
12.4 8.3 14.6 11.2 17.9
1.2 0.1 1.2 0.0 0.9
repair.ir forn re
65-74remarkably similar to the 30-day mortality of 1.2% for
of stay; OAR, open aneurysm repair; OR, odds ratio.
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ised Endovascular AneurysmManagement (DREAM) trial,
which compared these two procedures in patients whowere
candidates for both repairs.3
We found additional advantages of EVAR in terms of
major complications, length of stay, and proportion of
routine discharge that affirms a substantial reduction in the
immediate postoperative risks provided by this approach.
Although the advantage of EVAR for perioperative surgical
outcomes is evident for every age group, this advantage is
most pronounced for patients with advancing age. For
example, for patients aged 85 years, the in-hospital mor-
tality rate for OARwas more than five times that for EVAR.
Furthermore, among those who were discharged alive in
this oldest-old group, only 50% were discharged to home
after OAR, whereas 85% were routinely discharged to
home after EVAR. Pulmonary, cardiovascular, and renal
complications were also dramatically reduced for these
elderly patients who had EVAR.
It is important to note two distinct and recent publica-
tions using the Medicare claims database from 2001 to
2003.11,27 Both studies showed similar results with respect
to short-term EVAR outcomes for elderly patients, analo-
gous to our study, which used the NIS database. This study
extends these findings about EVAR utilization past 2003,
which the NIS analysis indicates was the fulcrum at which
the use of EVAR exceeded OAR for elective AAA repair.
Interestingly, we have shown a perpetuation of that trend,
whereby preference for EVAR continued to increase and
accounted for 71.9% of AAA repairs in 2006.
It is notable that this shift is most dramatic for patients
aged 85 years. Although the combined utilization of
OAR and EVAR for intact AAAs remained stable or de-
clined in all other age groups, patients aged 85 years saw
a substantial increase in the performance of any AAA repair
from 2001 to 2006. The expansion of the pool of candi-
dates for AAA surgery can be explained by the reduced
short-term risk profile provided by EVAR, which has of-
fered physicians and patients a more palatable choice for
intervention, pushing overall operative rates higher.
Although EVAR certainly confers a short-term survival
advantage for this older group compared with OAR, we
cannot determine whether a long-term survival advantage
was achieved for this group compared with a noninterven-
tional choice. Certainly, existing data from two large ran-
domized controlled trials comparing repair types demon-
strate loss of this short-term survival advantage after only 2
years of follow-up, but these studies did not stratify patients
by age.3,4 Furthermore, no survival advantage (from all
causes) from EVAR versus nonintervention was demon-
strated at 4 years for nonoperative candidates, and these
patients were a mean age of 76.28
Given advanced age and higher prevalence of comor-
bidities, the survival advantage from either OAR or EVAR
may be limited in patients aged 85 years. One case series
that examined this question found no long-term survival
advantage for EVAR versus OAR for patients aged 80Table IV. Risk-adjusted length of stay, in-hospital
mortality, disposition and complication
Complication
Risk-adjusted OR (95% CI)
PFor LOS
LOS d
All ages EVAR: 2.99 (2.97-3.01) .001
OAR: 8.55 (8.53-8.57)
50-64 y EVAR: 2.50 (2.47-2.54) .001
OAR: 7.30 (7.26-7.33)
65-74 y EVAR: 2.84 (2.82-2.87) .001
OAR: 8.20 (8.17-8.22)
75-84 y EVAR: 3.19 (3.16-3.21) .001
OAR: 9.52 (9.49-9.55)
85 y EVAR: 3.54 (3.48-3.61) .001
OAR: 9.91 (9.82-10.02)
For EVAR vs OAR
In-hospital mortality
All ages 0.23 (0.19-0.28) .001
50-64 y 0.25 (0.11-0.58) .001
65-74 y 0.37 (0.27-0.52) .001
75-84 y 0.20 (0.15-0.26) .001
85 y 0.18 (0.10-0.31) .001
Disposition to home
All ages 3.95 (3.62-4.31) .001
50-64 y 2.51 (1.73-3.66) .001
65-74 y 3.00 (2.55-3.54) .001
75-84 y 4.24 (3.77-4.76) .001
85 y 5.17 (3.95-6.75) .001
Complications
Any
All ages 0.27 (0.25-0.28) .001
50-64 y 0.27 (0.23-0.32) .001
65-74 y 0.25 (0.23-0.28) .001
75-84 y 0.29 (0.27-0.32) .001
85 y 0.23 (0.18-0.29) .001
Cardiovascular
All ages 0.33 (0.30-0.37) .001
50-64 y 0.31 (0.23-0.43) .001
65-74 y 0.36 (0.30-0.43) .001
75-84 y 0.33 (0.28-0.39) .001
85 y 0.27 (0.18-0.40) .001
Pulmonary
All ages 0.16 (0.15-0.18) .001
50-64 y 0.17 (0.13-0.23) .001
65-74 y 0.21 (0.18-0.24) .001
75-84 y 0.15 (0.13-0.18) .001
85 y 0.09 (0.06-0.13) .001
Acute renal failure
All ages 0.24 (0.21-0.27) .001
50-64 y 0.27 (0.18-0.41) .001
65-74 y 0.23 (0.18-0.28) .001
75-84 y 0.26 (0.22-0.31) .001
85 y 0.18 (0.11-0.30) .001
Bleeding
All ages 0.50 (0.46-0.54) .001
50-64 y 0.47 (0.37-0.59) .001
65-74 y 0.40 (0.34-0.45) .001
75-84 y 0.59 (0.53-0.67) .001
85 y 0.61 (0.45-0.82) .001
CI, Confidence interval; EVAR, endovascular aneurysm repair; LOS, lengthyears.29 Furthermore, this case series demonstrated that
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either method had a significantly higher mortality rate over
time than the general population of patients aged 80
years. 30 Given the rapid diffusion of this new technology
into a previously untreated group of patients with AAA
primarily created by the introduction of EVAR for patients
ages 85 that is shown here, the question of long-term
survival and freedom from aneurysm-related death require
further investigation.
Surgical management with EVAR may offer other ad-
vantages to these elderly patients beyond improved survival
and freedom from aneurysm-related death. Freedom from
anxiety and fear of AAA rupture31,32 may now be worth the
risk of AAA repair for these elderly patients given the
dramatically improved risk profile and the likelihood of
home discharge for most of them. In addition, there is a
well documented cohort of patients aged 80 years who
have a relatively long life expectancy,26 and the mortality
benefit for this group conferred by EVAR may be signifi-
cant. Unfortunately, the prevalence of aneurysmal disease
in this oldest-old group is currently unknown.
This study has some limitations. The NIS does not
contain data from all 50 states and may not represent the
population of all the hospitals within the states where the
data were collected, leaving our results subject to sample
bias. Our analysis is also limited by the completeness and
accuracy of coding. Discrete end points such as in-hospital
death are generally accurate, but preoperative comorbidi-
ties and in-hospital complications are subject to interpreta-
tion and bias. Most importantly, we are limited by the
variables available in the database. We could not assess the
severity of the comorbidities or the complications, nor were
there any records for the size of the AAAs.
Even given the limitations of the NIS database, how-
ever, we believe it is a valuable resource to assess broad
trends in the nation and estimate immediate surgical out-
comes including death from AAA repair. The large volume
of data collected over years from multiple tiers of hospitals
gives this database an advantage relative to smaller individ-
ual case series that generally reflect experience of a single
institution or surgeon.
CONCLUSIONS
This study provides outcome analysis on elective AAA
repairs from a population perspective. We found that short-
term surgical outcomes are consistently favorable for
EVAR, and thus endovascular techniques have replaced
open repair as the more common operation for elective
AAA repair. Older patients receive the largest advantage
from the surgical risk-reduction offered by EVAR, which
likely explains the dramatic increase in the total number of
patients aged 85 years undergoing AAA repair, primarily
using EVAR. Further investigation is necessary to deter-
mine whether this expansion of the indications for AAA
repair created by the introduction new technology im-
proves long-term survival, freedom from aneurysm-related
mortality and quality of life.AUTHOR CONTRIBUTIONS
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cal Modification.
aExcluding cases with concurrent codes of 430, 431, 432, 435, or 436.
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comorbidities16,18
Comorbidities ICD-9-CM codes
Coronary
Old myocardial infarction 412
Coronary atherosclerosis 414.0
Aneurysm and dissection of heart 414.1
Other specified or unspecified chronic
ischemic heart disease 414.8, 414.9
Hypertensive heart disease 402
Unspecified cardiovascular disease 429.2
Cerebral
Occlusion and stenosis of precerebral arteries 433
Occlusion of cerebral arteries 434
Other and ill-defined cerebrovascular disease 437
Late effect of cerebrovascular diseasea 438
Peripheral vascular disease
Atherosclerosis 440
Unspecified peripheral vascular disease 443.9
Chronic obstructive pulmonary disease
Chronic bronchitis 491
Emphysema 492
Asthma 493
Bronchiectasis 494
Chronic airway obstruction, not elsewhere
specified 496
Pneumoconiosis 500-505
Chronic respiratory conditions due to fumes
and vapors 506.4
Diabetes
Diabetes mellitus 250
Chronic renal insufficiency
Hypertensive renal disease 403
Chronic glomerulonephritis 582
Chronic renal failure 585
ICD-9-CM, International Classification of Diseases, Ninth Revision, Clini-
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Complications ICD-9-CM codes
Cardiovascular complications
Cardiac arrest/insufficiency; heart failure during or resulting from a procedure 997.1
Acute myocardial infarction 410.0-410.9
Postoperative stroke 997.02
Postoperative deep venous thrombosis 997.79
Postoperative pulmonary embolism 415.11
Phlebitis or thrombophlebitis from procedure 997.2
Pulmonary complications
Mendelson syndrome or pneumonia resulting from a procedure 997.3
Acute respiratory failure 518.81
Postoperative acute respiratory insufficiency 518.5
Postoperative pulmonary edema, or acute pulmonary edema 518.4
Postoperative pneumothorax 512.1
Acute renal failure 584.5-584.9
Infection
Postoperative infection 998.5, 998.51, 998.59
Infection and inflammatory reaction due to other vascular device, implant, and graft (arterial graft,
arteriovenous fistula or shunt, infusion pump, vascular catheter) 996.62
Severe sepsis 995.92
Septicemia 038.0-038.9
Septic shock 785.52
Postoperative shock 998.0
Bleeding
Acute posthemorrhagic anemia (anemia due to acute blood loss) 285.1
Hemorrhage or hematoma or seroma complicating a procedure 998.1, 998.11, 998.12, 998.13
Wound complications
Delayed wound healing 998.83
Disruption of operative wound 998.3
Persistent postoperative fistula 998.6ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification.
